The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bayer Health; Lilly; Novartis; PharmaMar
Consulting or Advisory Role - Bayer; Eisai; Lilly
Research Funding - PharmaMar
Randomized comparison of pazopanib (PAZ) and doxorubicin (DOX) in the first line treatment of metastatic soft tissue sarcoma (STS) in elderly patients (pts): Results of a phase II study (EPAZ).
 
Viktor Grünwald
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; MSD
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; Eisai; Exelixis; Ipsen; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; PharmaMar; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Cerulean Pharma; ClinSol; Ipsen; Lilly; MSD Oncology; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Novartis (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer
 
Annegret Kunitz
No Relationships to Disclose
 
Markus Kajo Schuler
Research Funding - Novartis
 
Patrick Schoffski
Consulting or Advisory Role - Blueprint Medicines (Inst); Eisai (Inst); Ellipses Pharma (Inst); Epizyme (Inst); Ipsen (Inst); Lilly (Inst); Loxo (Inst); Piqur (Inst); Plexxikon (Inst)
Research Funding - Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); CoBioRes NV (Inst); Eisai (Inst); Exelixis (Inst); G1 Therapeutics (Inst); Lilly (Inst); Novartis (Inst); PharmaMar (Inst); Plexxikon (Inst)
 
Hans-Georg Kopp
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Sanofi
Expert Testimony - IcoPharma; Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; Lilly; MSD; Novartis; Sanofi
 
Sebastian Bauer
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer; Pharmamar
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Lilly; Nanobiotix
Research Funding - Blueprint Medicines; Incyte (Inst); Novartis
Travel, Accommodations, Expenses - Pharmamar
 
Bernd Kasper
No Relationships to Disclose
 
Lars H Lindner
Consulting or Advisory Role - Eisai; EL Medconsult; Lilly; Novartis
Speakers' Bureau - PharmaMar
Research Funding - Sennewald GmbH
Travel, Accommodations, Expenses - PharmaMar
 
Jens-Marcus Chemnitz
Honoraria - Ablynx
Consulting or Advisory Role - Ablynx; Amgen
Travel, Accommodations, Expenses - Amgen; PharmaMar
 
Martina Margrit Crysandt
No Relationships to Disclose
 
Alexander Stein
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck KGaA; MSD; Roche
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Lilly; Merck KGaA; Roche; Sanofi; Servier
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Bjoern Steffen
Travel, Accommodations, Expenses - Amgen; GlaxoSmithKline; Lilly; Novartis; PharmaMar
 
Gerlinde Egerer
Consulting or Advisory Role - MSD
Speakers' Bureau - MSD; PharmaMar
Travel, Accommodations, Expenses - Astellas Medivation; MSD
 
Silke Zimmermann
No Relationships to Disclose
 
Annika Karch
No Relationships to Disclose